A 45,X/47,XYY/46,XY KARYOTYPE AND Y CHROMOSOME MICRODELETION IN AN INFERTILE MALE
Bulakbasi T1, Sahin FI1,*, Yil maz Z1, Zeyneloglu HB2
*Corresponding Author: Professor Dr. Feride Iffet Sahin, Department of Medical Genetics, Faculty of Medicine, Baskent University, Kubilay Sokak No:36, Maltepe 06570, Ankara, Turkey; Tel : +90-312-2324400; Fax : +90-312-2319134; E-mail: feridesahin@hotmail.com
page: 51

DISCUSSION

 

The relationship between infertility and chromosomal abnormalities has been well documented over the past 25 years [2]. Since an increase in chromosomal abnormalities correlates with a decrease in sperm count, abnormalities in sperm count are the most important indications for chromosome analysis in infertile males [2]. Numerical sex chromosome aberrations constitute a small percentage of the anomalies; since only 3.32% were reported in a study of 2,196 infertile men; and they tend to have a broad spectrum of phenotypic effects [2]. Our patient revealed a 45,X/46,XY mosaicism during routine blood analysis. This karyotype was found in seven cases in the same study [2]. Our patient was infertile because of azoospermia, but he also had a Yq microdeletion covering the AZFb and AZFc regions. It has been reported that numerical Y chromosomal defects may accompany Yq microdeletions, as deleted regions tend to be lost during cell division as a result of mitotic instability [6,7]. There is a close association between large Yq deletions and gonosomal mosaicism in both somatic and germinal cells [5,7]. As in our case, mosaicism in germinal cells may remain undetected unless a specific analysis is performed. We first detected the 47,XYY cell line cytogenetically in testicular tissue and confirmed its presence by FISH analysis in 23% of these cells. The FISH analysis of peripheral lymphocytes revealed the same finding in 8% of cells, which were not identified by conventional cytogenetics. The cases of sex chromosome mosaicism reported in the literature show great diversity, from Turner Syndrome to patients with ambiguous genitalia [9]. The karyotypes with 45,X and 47,XYY cell lines could both present as males and females phenotypically and features like short stature or gonadal tumors have also been reported [9]. Our patient is an apparently normal male, except for the azoo spermia which could be due to the coexistence of a Yq microdeletion. The dominant cell line present in different tissues correlate with the cases reported before. Our patient had different percentages of the 47,XYY cell line in different tissues, as expected in these mosaic states, and this variation may explain the diversity of the phenotypes seen in these patients [3,9]. The formation of 45,X/47,XYY/46,XY mosaicism may be caused by at least two mechanisms. The first is paternal non disjunction at meiosis II followed by loss of the chromosome in subsequent mitoses. The second is a post-zygotic mitotic error which explains the different amounts of mosaicism present in different tissues [3]. Either mechanism could be the cause of mosaicism in our patient, while the presence of Yq microdeletion makes him especially interesting. When sex chromosomal aneuploidy is detected in infertile males, it should be remembered that Yq micro deletions may accompany the clinical picture as they may induce mitotic instability of the Y chromosome, and cause mosaicism that may be undetected in blood cells, but make considerable contribution to the germinal tissue. Evaluation of infertile males with spermatogenetic defects for gonosomal mosaicism could lead to a better assessment for estimating the outcome of assisted reproduction techniques. This case demonstrates the use of testicular biopsy material as another tissue to be karyotyped. The second tissue in this case revealed a third line of cells with gono somal aberration and contributed to predicting an outcome and shaping the genetic counseling for this patient.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006